Related Experiment Video
Updated: Jan 16, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Staphylococcus aureus adaptation to vancomycin influences phage susceptibility
Jack Å H Abrahamsson1, Esther Lehmann1, Anaëlle Fait2
1Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870, Copenhagen, Denmark.
Abstract:
Phages are bacterial viruses considered as therapeutics for treatment of serious infections with antibiotic-resistant pathogens. In Staphylococcus aureus, resistance to cell wall targeting antibiotics is common in the methicillin resistant (MRSA) or vancomycin-intermediate susceptible (VISA) strains. Furthermore, the cell wall anchors the primary phage receptor, the wall teichoic acid (WTA) glycopolymers. Here we demonstrate that mutations resulting in VISA development affect phage susceptibility of clinically and laboratory evolved strains. For clinical strains we observed both increased and decreased susceptibility compared to the ancestral vancomycin susceptible strains when infected with the therapeutically relevant myoviruses, ΦIPLA-RODI, Stab20, Stab21 and ΦK. For laboratory strains adapted to vancomycin from the MRSA strain, JE2, we observed variable resistance development to the phages ΦIPLA-RODI, Stab21 and ΦK with one strain becoming completely phage resistant. In contrast, half of the VISA strains became susceptible to Stab20 to which JE2 is resistant. These changes in part correlated with altered WTA glycosylation patterns as shown by WTA-specific antibodies and for the resistant strain resulted in compromised phage therapy as shown in a Galleria mellonella infection model. This study highlights the need for understanding antibiotic-driven alterations in bacterial physiology when developing phage-based therapies using combination treatments with antibiotics and phages.
Insights
Bacterial phages show altered efficacy against Staphylococcus aureus strains with vancomycin-intermediate susceptibility (VISA). VISA development can change phage susceptibility, impacting phage therapy effectiveness and necessitating careful consideration of antibiotic-drug interactions.
Area of Science:
- Microbiology
- Bacteriology
- Virology
Background:
- Bacterial phages are promising therapeutics against antibiotic-resistant pathogens.
- Staphylococcus aureus strains, particularly methicillin-resistant (MRSA) and vancomycin-intermediate susceptible (VISA) strains, commonly exhibit resistance to antibiotics.
- Wall teichoic acid (WTA) glycopolymers on the bacterial cell wall serve as primary phage receptors.
Purpose of the Study:
- To investigate how mutations leading to vancomycin-intermediate susceptibility affect phage susceptibility in Staphylococcus aureus.
- To evaluate the impact of antibiotic-driven physiological changes on phage therapy efficacy.
- To explore the relationship between WTA glycosylation and phage resistance.
Main Methods:
- Analysis of phage susceptibility in clinical and laboratory-evolved VISA strains of Staphylococcus aureus.
- Infection modeling using therapeutically relevant myoviruses (ΦIPLA-RODI, Stab20, Stab21, ΦK).
- Assessment of WTA glycosylation patterns and phage therapy efficacy in a Galleria mellonella infection model.
Main Results:
- VISA development in Staphylococcus aureus led to variable changes in phage susceptibility, with some strains becoming more resistant and others more susceptible.
- Laboratory-evolved VISA strains showed resistance to certain phages, while some became susceptible to previously resistant phages.
- Altered WTA glycosylation correlated with changes in phage susceptibility, and resistance compromised phage therapy effectiveness in vivo.
Conclusions:
- Antibiotic-induced alterations in bacterial physiology, specifically WTA glycosylation, significantly impact phage susceptibility in Staphylococcus aureus.
- Understanding these changes is crucial for developing effective phage-based therapies, especially when used in combination with antibiotics.
- Future phage therapy strategies must account for antibiotic-driven bacterial adaptations to ensure successful treatment outcomes.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Lysogenic Cycle of Bacteriophages
Antibiotic Selection
Lytic Cycle of Bacteriophages

